Ralph Lauren’s Financial Results Beat Wall Street Targets
Clothing retailer Ralph Lauren (RL) has reported fiscal fourth-quarter financial results that surpassed Wall Street estimates. The New York-based company known for its Polo shirts announced earnings per share (EPS) of $2.03 U.S., which was ahead of the $2 U.S. consensus expectation of analysts. The upscale clothing designer said that its revenue in the period totaled $1.70 billion U.S., which was ahead of the $1.63 billion U.S. forecast on Wall Street.Management attributed the strong results to resilient demand for its classic Polo shirts and spring wear.Additionally, the company’s efforts to attract younger and less price-sensitive consumers are starting to payoff, said management. Despite the strong print, Ralph Lauren forecast full-year revenue below Wall Street estimates, citing uncertainty from U.S. import tariffs.The company manufactures much of its clothing overseas, notably in Asian countries such as China and Vietnam that are subject to steep import duties. Looking ahead, management at Ralph Lauren said they expect fiscal 2026 revenue to increase in the low-single digits from last year.Analysts had estimated a rise of 4.39% in the company’s sales this fiscal year.The stock of Ralph Lauren has risen 18% this year to trade at $273.88 U.S. per share.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


